Featured Research

from universities, journals, and other organizations

By 2020, 76 Million Worldwide Could Go Blind Without Prevention; Vision 2020 Initiative Could Cut Figure By Nearly Two-thirds

Date:
March 31, 2003
Source:
Johns Hopkins University Bloomberg School Of Public Health
Summary:
Over 52 million people worldwide can avoid going blind if current and new resources are successfully implemented, according to a new study. Researchers for the Johns Hopkins Bloomberg School of Public Health and the London School of Hygiene and Tropical Medicine found that without extra intervention, the global number of blind individuals would increase from 44 million in 2000 to 76 million in 2020.

Over 52 million people worldwide can avoid going blind if current and new resources are successfully implemented, according to a new study. Researchers for the Johns Hopkins Bloomberg School of Public Health and the London School of Hygiene and Tropical Medicine found that without extra intervention, the global number of blind individuals would increase from 44 million in 2000 to 76 million in 2020.

"Vision 2020 - The Right to Sight," an initiative cosponsored by the World Health Organization and the International Agency for the Prevention of Blindness, is aimed at eliminating avoidable blindness from cataract, trachoma, onchocerciasis, vitamin A deficiency and refractive errors, would decrease the 2020 projection by 52 million individuals. The economic gain of this program would be approximately $102 billion. The study, "The Magnitude and Cost of Global Blindness: An Increasing Problem That Can Be Alleviated," will appear in the April 2003 issue of the American Journal of Ophthalmology.

Researchers used existing data and epidemiologic models to estimate blindness prevalence, and combined these and other data on national populations, gross domestic product per capita, labor force participation and unemployment rates to project the economic productivity loss associated with blindness. The global loss could grow from $42 billion to $110 billion if efforts to decrease vision loss do not change.

Kevin D. Frick, PhD, lead author of the study and associate professor in the Department of Health Policy and Management in the School, said, "The economic costs of blindness can be decreased by either finding ways to facilitate economic productivity of individuals who are or will become blind or eliminating avoidable blindness. VISION 2020 is an initiative aimed at the latter goal. If VISION 2020 were to be successful at decreasing the prevalence of blindness in all regions of the world to near the levels that are found in the established market economies today, a conservative estimate of the economic gain from increased productivity is $102 billion."

Dr. Frick and his co-author projected that the aging and growth of the global population over the next 20 years will lead to a large increase in the number of blind persons. The researchers state that this increase could be avoided by using existing and new resources at the causes of blindness for which proven interventions are available, such as cataract surgery.

Dr. Frick said, "Blindness and low vision are public health problems that will increase because of demographic trends unless there are additional interventions. If successful, VISION 2020 will reduce avoidable blindness by 429 million blind person-years and a minimum saving of $102 billion for unaccommodated blindness along from 2003 to 2020."

Allen Foster, FRCS, FRCOphth, Medical Director of Christoffel-Blindenmission through the London School of Hygiene and Tropical Medicine, co-authored the study.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School Of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University Bloomberg School Of Public Health. "By 2020, 76 Million Worldwide Could Go Blind Without Prevention; Vision 2020 Initiative Could Cut Figure By Nearly Two-thirds." ScienceDaily. ScienceDaily, 31 March 2003. <www.sciencedaily.com/releases/2003/03/030331043944.htm>.
Johns Hopkins University Bloomberg School Of Public Health. (2003, March 31). By 2020, 76 Million Worldwide Could Go Blind Without Prevention; Vision 2020 Initiative Could Cut Figure By Nearly Two-thirds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2003/03/030331043944.htm
Johns Hopkins University Bloomberg School Of Public Health. "By 2020, 76 Million Worldwide Could Go Blind Without Prevention; Vision 2020 Initiative Could Cut Figure By Nearly Two-thirds." ScienceDaily. www.sciencedaily.com/releases/2003/03/030331043944.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins